NO20043246L - Nye fremgangsmater til diagnose og behandling av tumorer - Google Patents
Nye fremgangsmater til diagnose og behandling av tumorerInfo
- Publication number
- NO20043246L NO20043246L NO20043246A NO20043246A NO20043246L NO 20043246 L NO20043246 L NO 20043246L NO 20043246 A NO20043246 A NO 20043246A NO 20043246 A NO20043246 A NO 20043246A NO 20043246 L NO20043246 L NO 20043246L
- Authority
- NO
- Norway
- Prior art keywords
- tumors
- diagnosis
- treatment
- new methods
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02000315 | 2002-01-03 | ||
US35870202P | 2002-02-25 | 2002-02-25 | |
PCT/EP2003/000009 WO2003055917A2 (en) | 2002-01-03 | 2003-01-02 | Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043246L true NO20043246L (no) | 2004-08-02 |
Family
ID=26077560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043246A NO20043246L (no) | 2002-01-03 | 2004-08-02 | Nye fremgangsmater til diagnose og behandling av tumorer |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040001790A1 (ru) |
EP (2) | EP1461360B1 (ru) |
JP (2) | JP2005523887A (ru) |
CN (1) | CN1612895B (ru) |
AU (1) | AU2003210149B2 (ru) |
BR (1) | BR0306715A (ru) |
CA (1) | CA2468081A1 (ru) |
CY (1) | CY1110923T1 (ru) |
HK (1) | HK1076474A1 (ru) |
IL (2) | IL162201A0 (ru) |
MX (1) | MXPA04006517A (ru) |
NO (1) | NO20043246L (ru) |
PL (1) | PL369371A1 (ru) |
RU (1) | RU2352582C2 (ru) |
WO (1) | WO2003055917A2 (ru) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
US20030176663A1 (en) * | 1998-05-11 | 2003-09-18 | Eidgenossische Technische Hochscule | Specific binding molecules for scintigraphy |
US20030045681A1 (en) * | 1998-05-11 | 2003-03-06 | Anthony J. Zelano | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
JP2003524018A (ja) | 2000-02-24 | 2003-08-12 | アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ | フィブロネクチンのed‐bドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用 |
BR0113737A (pt) * | 2000-09-07 | 2004-02-25 | Schering Ag | Receptor do domìnio da edbfibronectina (11) |
ES2337566T3 (es) | 2002-03-11 | 2010-04-27 | Philogen S.P.A. | Anticuerpos derivados de anti ed-b l19 y vasculatura tumoral objetivo. |
EP1514561A1 (en) * | 2003-09-10 | 2005-03-16 | Philogen S.p.A. | Targeting of tumor vasculature using radiolabelled antibody L19 against fibronectin ED-B |
DE10348319A1 (de) * | 2003-10-17 | 2005-05-19 | Schering Ag | Bindemoleküle für die Extra-Domäne B von Fibronectin zur Detektion von atherosklerotischen Plaques |
ATE374367T1 (de) * | 2004-07-22 | 2007-10-15 | Bayer Schering Pharma Ag | Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind |
US20060039863A1 (en) * | 2004-07-22 | 2006-02-23 | Michael Schirner | Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
US7785591B2 (en) | 2004-10-14 | 2010-08-31 | Morphosys Ag | Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
ES2291071B1 (es) * | 2005-06-13 | 2009-03-16 | Proyecto De Biomedicina Cima, S.L. | Agentes y metodos basados en el uso del dominio eda de la fibronectina. |
JP2009535372A (ja) * | 2006-05-03 | 2009-10-01 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 抗edbフィブロネクチンドメイン抗体l19−sip及び抗−egfr−抗体の組合せ |
KR101515243B1 (ko) * | 2007-04-02 | 2015-04-24 | 필로겐 에스.피.에이. | 종양 전이암의 신생혈관과 관련된 피브리노겐의 ed―a 항원 |
EP2036576A1 (en) * | 2007-09-17 | 2009-03-18 | Bayer Schering Pharma Aktiengesellschaft | ED-B fibronectin as stratification marker for antitumor drugs |
US8253725B2 (en) * | 2007-12-28 | 2012-08-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and system for generating surface models of geometric structures |
EP2116555A1 (en) | 2008-05-08 | 2009-11-11 | Bayer Schering Pharma Aktiengesellschaft | Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma |
EP2456472B1 (en) | 2009-07-22 | 2024-03-27 | Actinium Pharmaceuticals, Inc. | Methods for generating radioimmunoconjugates |
JP5892540B2 (ja) * | 2009-12-25 | 2016-03-23 | 国立研究開発法人理化学研究所 | 生体内にて標的組織に指向する放射標識化合物およびその利用 |
WO2011110490A1 (en) | 2010-03-09 | 2011-09-15 | Bayer Pharma Aktiengesellschaft | Process for the production of radioactively labelled scfv antibody fragments, kits and compositions |
CN104215668A (zh) * | 2014-08-25 | 2014-12-17 | 浙江大学 | 基于theed纤维阵列的二氧化碳传感器及其制备方法 |
US20180340936A1 (en) * | 2015-11-16 | 2018-11-29 | Hefei Lifeon Pharmaceutical Co. Ltd. | Use of ed-b protein in diagnosis of tissue hyperplasia |
EP3525828A1 (en) * | 2016-10-17 | 2019-08-21 | Pfizer Inc | Anti-edb antibodies and antibody-drug conjugates |
EP4389146A2 (en) * | 2020-05-22 | 2024-06-26 | Philogen S.p.A. | Tnf-a immunoconjugate therapy for the treatment of brain tumors |
AU2022310862A1 (en) | 2021-07-14 | 2024-02-01 | Regeneron Pharmaceuticals, Inc. | Engineered t cell receptors fused to binding domains from antibodies |
WO2023196997A2 (en) | 2022-04-08 | 2023-10-12 | 2Seventy Bio, Inc. | Multipartite receptor and signaling complexes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3070763B2 (ja) * | 1989-08-09 | 2000-07-31 | ロメッド インコーポレイティド | テクネチウムまたはレニウムでの抗体または他のタンパク質の直接放射能標識 |
AU675929B2 (en) * | 1992-02-06 | 1997-02-27 | Curis, Inc. | Biosynthetic binding protein for cancer marker |
GB9324807D0 (en) * | 1993-12-03 | 1994-01-19 | Cancer Res Campaign Tech | Tumour antibody |
GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
TWI259837B (en) * | 1998-05-11 | 2006-08-11 | Eidgenossische Tech Hochscule | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
US6171578B1 (en) * | 1999-04-14 | 2001-01-09 | Diatide, Inc. | Benzodiazepine derivatives for imaging thrombi |
KR100816572B1 (ko) * | 1999-04-28 | 2008-03-24 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 항-vegf 항체 및 이를 포함하는 약제학적 조성물 |
JP2003524018A (ja) | 2000-02-24 | 2003-08-12 | アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ | フィブロネクチンのed‐bドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用 |
-
2003
- 2003-01-02 RU RU2004123785/13A patent/RU2352582C2/ru not_active IP Right Cessation
- 2003-01-02 WO PCT/EP2003/000009 patent/WO2003055917A2/en active Application Filing
- 2003-01-02 AU AU2003210149A patent/AU2003210149B2/en not_active Revoked
- 2003-01-02 MX MXPA04006517A patent/MXPA04006517A/es active IP Right Grant
- 2003-01-02 BR BR0306715-7A patent/BR0306715A/pt not_active Application Discontinuation
- 2003-01-02 CN CN038019434A patent/CN1612895B/zh not_active Withdrawn - After Issue
- 2003-01-02 IL IL16220103A patent/IL162201A0/xx unknown
- 2003-01-02 JP JP2003556447A patent/JP2005523887A/ja not_active Withdrawn
- 2003-01-02 CA CA002468081A patent/CA2468081A1/en not_active Withdrawn
- 2003-01-02 EP EP03726977A patent/EP1461360B1/en not_active Expired - Lifetime
- 2003-01-02 EP EP10162295A patent/EP2239274A1/en not_active Withdrawn
- 2003-01-02 PL PL03369371A patent/PL369371A1/xx unknown
- 2003-01-03 US US10/336,041 patent/US20040001790A1/en not_active Abandoned
-
2004
- 2004-05-27 IL IL162201A patent/IL162201A/en not_active IP Right Cessation
- 2004-08-02 NO NO20043246A patent/NO20043246L/no unknown
-
2005
- 2005-09-22 HK HK05108339.8A patent/HK1076474A1/xx not_active IP Right Cessation
-
2009
- 2009-05-29 JP JP2009129965A patent/JP4663020B2/ja not_active Expired - Lifetime
-
2010
- 2010-11-17 CY CY20101101038T patent/CY1110923T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HK1076474A1 (en) | 2006-01-20 |
AU2003210149A1 (en) | 2003-07-15 |
AU2003210149B2 (en) | 2008-10-09 |
US20040001790A1 (en) | 2004-01-01 |
WO2003055917A3 (en) | 2003-12-24 |
EP1461360A2 (en) | 2004-09-29 |
BR0306715A (pt) | 2004-12-28 |
WO2003055917A2 (en) | 2003-07-10 |
RU2004123785A (ru) | 2005-08-10 |
IL162201A0 (en) | 2005-11-20 |
EP1461360B1 (en) | 2010-08-18 |
PL369371A1 (en) | 2005-04-18 |
MXPA04006517A (es) | 2005-03-31 |
JP2005523887A (ja) | 2005-08-11 |
EP2239274A1 (en) | 2010-10-13 |
CA2468081A1 (en) | 2003-07-10 |
IL162201A (en) | 2011-04-28 |
RU2352582C2 (ru) | 2009-04-20 |
CN1612895B (zh) | 2010-05-12 |
JP4663020B2 (ja) | 2011-03-30 |
CY1110923T1 (el) | 2015-06-10 |
CN1612895A (zh) | 2005-05-04 |
JP2009209149A (ja) | 2009-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043246L (no) | Nye fremgangsmater til diagnose og behandling av tumorer | |
NO20023402D0 (no) | Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft | |
NO20034020L (no) | Nye MHC molekylforbindelser, og metoder for anvendelse av disse forbindelsene for diagnose og terapi, og anvendelse av MHC molekyler | |
NO20050570L (no) | Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander | |
NO20030714D0 (no) | Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter | |
DK1530724T3 (da) | Diagnose og forebyggelse af cancercelleinvasion | |
NO20052760D0 (no) | Fremgangsmate for behandling av kreft og beslektede fremgangsmater. | |
DE602004021618D1 (de) | Diagnostische testvorrichtung und anwendungsverfahren dafür | |
CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
NO20013002L (no) | Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft | |
IS8071A (is) | Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum | |
EP1571968A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS | |
DE60332649D1 (de) | Mehrlumige struktur für eine implantierbare medizinische vorrichtung | |
NO20043359L (no) | Anordning for ikke-invasiv ultralydbehandling av et objekt | |
NO20050569D0 (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
EP1572091A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS | |
EP1578996A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS | |
NO20053874D0 (no) | Formulering og metoder for behandling av thrombocytemi | |
EP1575571A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR | |
IS8497A (is) | Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma | |
NO20054049D0 (no) | Fremgangsmate for diagnose og behandling. | |
DE602006008566D1 (de) | EKG-Aufnahmegerät und Verwendungsverfahren | |
DE60308985D1 (de) | Ultraschallabbildungsgerät und Methode |